Related Experiment Video
Updated: Jun 17, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Characteristics and mechanisms of T-cell senescence: A potential target for cancer immunotherapy
Han Wu1, Junru Li1, Zhen Zhang1,2
1Biotherapy Center & Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Abstract:
Immunosenescence, the aging of the immune system, leads to functional deficiencies, particularly in T cells, which undergo significant changes. While numerous studies have investigated age-related T-cell phenotypes in healthy aging, senescent T cells have also been observed in younger populations during pathological conditions like cancer. This review summarizes the recent advancements in age-associated alterations and markers of T cells, mechanisms, and the relationship between senescent T cells and the tumor microenvironment. We also discuss potential strategies for targeting senescent T cells to prevent age-related diseases and enhance tumor immunotherapy efficacy.
Insights
Immunosenescence, the aging immune system, impairs T cells. This review explores T-cell changes, their role in cancer, and strategies to target senescent T cells for better health and cancer immunotherapy.
Area of Science:
- Immunology
- Gerontology
- Oncology
Background:
- Immunosenescence describes the aging of the immune system, characterized by functional decline, especially in T cells.
- Age-associated T-cell alterations are studied in healthy aging, but senescent T cells also appear in younger individuals with diseases like cancer.
Purpose of the Study:
- To review recent advancements in understanding age-associated T-cell alterations and markers.
- To elucidate the mechanisms driving T-cell senescence.
- To explore the interplay between senescent T cells and the tumor microenvironment.
Main Methods:
- Literature review of recent studies on immunosenescence and T-cell biology.
- Analysis of T-cell phenotypes, markers, and functional changes associated with aging.
- Examination of the role of senescent T cells in cancer pathogenesis and the tumor microenvironment.
Main Results:
- Identified key age-associated alterations and markers in T cells.
- Detailed mechanisms underlying T-cell senescence.
- Highlighted the complex relationship between senescent T cells and tumor progression and immune evasion.
Conclusions:
- Senescent T cells are implicated in both healthy aging and pathological conditions like cancer.
- Targeting senescent T cells presents a potential therapeutic strategy for age-related diseases.
- Modulating senescent T cells may enhance the efficacy of cancer immunotherapies.
More Related Videos
08:56Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
Published on: July 12, 2022
12:16A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
Published on: October 16, 2018
Related Concept Videos
Tumor Immunotherapy
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Replicative Cell Senescence
Cell-mediated Immune Responses
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...